1 asset in Musculoskeletal System Cancer
Therapeutic assets addressing Musculoskeletal System Cancer, rated under Floatz methodology v0.2 and sorted by current rating.
| Asset | Sponsor | Phase | Rating |
|---|---|---|---|
cd146/her2 car-t cells Musculoskeletal System Cancer | Essen Biotech | P1/2 | CC (47) |